Skip to main content
Premium Trial:

Request an Annual Quote

Data Call to Be Answered

Medical testing company Theranos has yielded to calls for it to publish data that it says shows its approach is accurate and reliable, the New York Times reports.

Earlier this month, the Wall Street Journal reported that Theranos wasn't using its own Edison technology for many of the tests it ran and raised questions about the tool's validity.

Theranos' chief executive Elizabeth Holmes said at a conference Monday sponsored by the Cleveland Clinic that publishing that data might better counteract what she said were unfair articles in the news media, as the Times reports.

"Data is a powerful thing because it speaks for itself," she said, according to the Times.

The Times notes that Theranos has long been secretive about its technology and hasn't published its data in peer-reviewed journals and instead has said that FDA approval would provide the best validation of its approach.

Holmes now says the company will do both. "We were never against that," she said. "I just always believed that as the FDA decision summaries came out one by one with our data, that actually that would be so much more transparent a model."

She did not say when or where the data would be published, the Times adds.